ONCOTYPE DXX
DEAD

Serial Number

88639660

Owner

Genomic Health, Inc.

Attorney

Sana Hakim

Filing Date

Oct 2, 2019

Add to watchlist:

No watchlists yet
View on USPTO

ONCOTYPE DXX Trademark

Serial Number: 88639660

ONCOTYPE DXX is a trademark filed by Genomic Health, Inc. on October 2, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Genomic Health, Inc. (72 trademarks)

301 Penobscot Drive
Redwood City, CA 94063

Entity Type: 03

Trademark Details

Filing Date

October 2, 2019

Registration Date

Not Registered

Published for Opposition

May 19, 2020

Goods & Services

Diagnostic kits comprised of medical diagnostic reagents and diagnostic assays for testing tissue samples and bodily fluids for use in cancer detection, analysis and prognosis; medical reagents; medical diagnostic reagents; kits for medical diagnostic purposes consisting primarily of enzymes for medical purposes, and also including nucleic acids, buffers, reagents and assays for use in disease testing and classification; diagnostic kits consisting primarily of enzymes for medical purposes, and also including nucleic acids, buffers, reagents and assays for use in disease testing and classification; medical diagnostic assays for testing of bodily fluids and tissue samples for use in disease detection and testing for medical and prognostic purposes; medical diagnostic reagents and assays for testing bodily fluids and tissue samples for use in disease testing and classification; enzyme preparations for medical purposes; biological preparations for the detection, diagnosis and monitoring of cancer for medical purposes; preparations for detecting genetic predispositions for medical purposes; biological preparations for use in the diagnosis, analysis and prognosis of cancer for medical purposes; diagnostic agents, preparations and substances for medical purposes

Assays for testing tissue samples and bodily fluids for scientific research in the field of cancer detection, analysis and prognosis; diagnostic assays for testing tissue samples and bodily fluids for scientific research in the field of cancer detection, analysis and prognosis; clinical diagnostic reagents; reagents for scientific or medical research use, namely, reagents for use in preparation of RNA samples; kits consisting primarily of enzymes for scientific and research purposes, and also including nucleic acids, buffers, reagents and assays for use in disease testing; diagnostic kits comprised primarily of diagnostic reagents for clinical or medical laboratory use and diagnostic assays for testing tissue samples and bodily fluids for clinical or medical laboratory use in cancer detection, analysis and prognosis; diagnostic kits comprised primarily of enzymes for scientific and research purposes, and also including nucleic acids, buffers, reagents and assays for use in disease testing; clinical diagnostic reagents

Medical testing for diagnostic and prognostic purposes in the field of cancer and disease classification; providing medical information to medical professionals in the form of reports in the field of cancer and disease classification

Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical testing services and information in the field of cancer research and disease classification

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Feb 16, 2021 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 15, 2021 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 14, 2020 NOAM
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 19, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 19, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 19, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 19, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 19, 2020 COAR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 19, 2020 NPUB
PUBLISHED FOR OPPOSITION
May 19, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 29, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 15, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 14, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 14, 2020 CRFA
ASSIGNED TO LIE
Apr 9, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 1, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 18, 2019 GNRN
NON-FINAL ACTION E-MAILED
Nov 18, 2019 GNRT
NON-FINAL ACTION WRITTEN
Nov 18, 2019 CNRT
ASSIGNED TO EXAMINER
Nov 11, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 6, 2019 NWOS
NEW APPLICATION ENTERED
Oct 5, 2019 NWAP